HCPLive Network

Prostate Cancer: Diagnostic Phase Episode

Urologist Dr. Jonathan Picard discusses the multidisciplinary review board approach employed at Hollings Cancer Center in order to optimize the course of care for each patient with a new prostate cancer diagnosis. In this podcast Dr. Picard walks through a typical sequence of events from the initial suspicion of prostate cancer through diagnosis of the disease.

Listen to this third-party podcast by clicking here.

Further Reading
A cancer analgesic has been awarded fast track status by the US Food and Drug Administration.
Cyramza (ramucirumab) has been approved by the US Food and Drug Administration to treat cancer of the stomach or gastroesophageal junction adenocarcinoma.
The drug Alprolix has been approved by the U.S. Food and Drug Administration as the first long-acting hemophilia B clotting agent, the FDA said in a news release.
More Reading